DC
AUPH icon

Diametric Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History

Diametric Capital’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Buy
+16,445
New +$263K 0.03% 404
2024
Q1 		– Sell
-19,572
Closed -$176K – 337
2023
Q4 		$176K Sell
19,572
-4,668
-19% -$38.4K 0.11% 210
2023
Q3 		$188K Buy
+24,240
New +$237K 0.08% 280

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Diametric Capital's AUPH Position: Q2 2026 in Review

Diametric Capital opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 16,445 shares worth $279K. The stake represents 0.03% of the portfolio and ranks #404 among its holdings. This is a return to the name: Diametric Capital previously reported a position in AUPH as recently as Q4 2023.

Diametric Capital first reported a position in AUPH in Q3 2023 and has held it in 3 quarters since. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Diametric Capital held 16,445 shares of Aurinia Pharmaceuticals worth $279K as of Q2 2026.
  • Aurinia Pharmaceuticals was a new Diametric Capital position in Q2 2026.
  • Aurinia Pharmaceuticals made up 0.03% of Diametric Capital's portfolio in Q2 2026, its #404 holding.
  • Diametric Capital first reported a position in Aurinia Pharmaceuticals in Q3 2023 and has held it in 3 quarters since.
  • 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Diametric Capital's 13F filing for Q2 2026, filed 14 Aug 2026.